January 27, 2023
November 1, 2022
Millions of patients each year are affected by knee osteoarthritis. The severity of this condition is often categorized using the Kellgren-Lawrence (KL) scale, which uses the numbers 0 through 4 to represent the absence or varying grades of symptom presentation. Patients with long-term and/or severe symptoms are often indicated for surgery, while patients with minimal symptoms can employ simpler tools, such as NSAIDS.
October 24, 2022
Gulf Coast Biologics Training and Education Center, Fort Myers FL, headed by Peter Everts, Ph.D., FRSM, is dedicated to providing the latest advancements in autologous regenerative medicine treatment options to physicians, practitioners, and health care providers across the globe. Many of those advances are increasingly dependent upon capturing and analyzing the large amounts of real-world data generated by everyday clinical cases.
September 28, 2022
It’s been two years since Health Canada released a position paper clarifying their regulations on autologous cell therapy products. Among their key requirements were redefining that “the process is the product” and that “products with proper process controls” could increase the probability that “products would be consistent in strength, quality and purity”. Thus, autologous cell therapies are “drugs” and are subject to the specific provisions for drugs under the Act.